Drug-Eluting Balloons

Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon

The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated balloon (DCB) for the interventional treatment of peripheral artery disease (PAD) for the superficial femoral and popliteal arteries in the upper leg....

Medtron IN-PACT SFA Trial, drug-eluted balloons

For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral ...

C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix 035 drug-coated balloon (DCB) catheter for percutaneous transluminal angioplasty (PTA) after pre-dilatation, for the treatment of de novo or restenotic l...

Boston Scientific Corp. CE mark Ranger Ranger Paclitaxel-coated PTA Balloon Cath

Boston Scientific received CE mark for the Ranger Paclitaxel-coated PTA Balloon Catheter. The technology is now in full European market launch. 

Covidien announced it has received CE Mark approval for its Stellarex drug-coated angioplasty balloon (DCB). 
Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon
The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated balloon (DCB) for the interventional treatment of peripheral...
balloon catheters, clinical trial/study, medtronic, IN.PACT Admiral drug-coated
The results of a landmark study published this month in Circulation indicate that a device from Medtronic Inc. called the IN.PACT Admiral drug-coated balloon (...
Cardionovum GmbH announced that it has initiated a 150-patient clinical study of its novel paclitaxel-releasing, high-pressure shunt balloon dilatation...
Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon
Medtronic’s In.Pact Admiral drug-coated balloon (DCB) is for the interventional treatment of peripheral artery disease (PAD) for the
The Lutonix 035 drug-coated balloon (DCB) catheter is for percutaneous transluminal angioplasty (PTA) after pre-dilatation, for the...
Medtronic's NC Euphora noncompliant balloon dilatation catheter was 510(k) cleared by the U.S. Food and Drug Administration (FDA) in...

Articles

Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon, DEB
The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated balloon (DCB) for the interventional treatment of peripheral...
For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug-coated balloon from Medtronic Inc....
FDA Clears Lutonix 035 Drug Coated Balloon C.R. Bard Inc.
C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix 035 drug-coated balloon (DCB) catheter for percutaneous...
A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from drug-...

Video Center

The America College of Cardiology has released its list of key late-breaking clinical trials at the...
4 days 16 hours ago
As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict...
3 weeks 4 days ago
There were a few intriguing technology trends at the Radiological Society of North America (RSNA)...
5 weeks 2 days ago
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...

Comparison Charts

Sorry there is no data available